• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Aging . Potential of biomarkers of ageing in predicting severity of influenza virus infection and vaccination efficacy

tetano

Editor, Senior Moderator
NPJ Aging


. 2025 Jul 1;11(1):56.
doi: 10.1038/s41514-025-00212-5. Potential of biomarkers of ageing in predicting severity of influenza virus infection and vaccination efficacy

Jing Yang[SUP] 1 [/SUP], Wei Ren[SUP] 2 [/SUP], Yi Ren[SUP] 3 [/SUP], Ting Yu[SUP] 4 [/SUP], Liaqat Ali[SUP] 5 [/SUP]



Affiliations
Abstract

Influenza virus infection contributing to the majority of viral pneumonia, acute cardiovascular and renal co-morbidities even death, is a worldwide public health concern caused by seasonal and pandemic influenza viruses. Unlike seasonal influenza, which occurred annually, the emerging of pandemic influenza every two to three decades for the distinctly reassorted influenza virus strains contributed to the broadly rapid spread and increased morbidity and mortality. While the majority of the influenza-infected population manifest no or only moderate influenza like illnesses symptoms, partial would progress to severe influenza illness and even die for the influenza-triggered complications. In this view, we collect and recapitulate various biomarkers that have been identified and may be employed in the clinical practices involved detection, treatment, and protection of individuals with a high risk of progression to severe influenza illnesses, as well as accurate track monitoring of influenza illnesses prognosis and applicability of therapeutic strategies. While numerous influenza-related deaths occurred in the aging and frail population, the biomarkers associated with increased susceptibility to severe influenza illnesses among the aging and frail patients were retrieved and outlined. Aging intertwined with frailty, they have similar physiological function decline processes resulting in dysfunction of host defense mechanisms and increased infection-related co-morbidities. Overall, these potential biomarkers associated with aging, frailty conditions, and impaired immune defense mechanisms are determinant factors of influenza illness severity through combining the baseline background and tipping points, as well as socioeconomic status disparity and psychosocial vulnerability being the shifting the trajectory and outcomes of influenza illnesses, particularly among the elder individuals.


 
Back
Top Bottom